State WA
Clinical Trials in Washington
Recruiting clinical trials with at least one study location in Washington. Data updated daily from ClinicalTrials.gov.
Top Conditions in Washington
Colorectal Cancer (8)Breast Cancer (7)Prostate Cancer (7)Malignant Solid Neoplasm (6)Acute Myeloid Leukemia (5)Melanoma (5)Non-small Cell Lung Cancer (5)Acute Lymphoblastic Leukemia (4)Ovarian Cancer (4)Hematopoietic and Lymphatic System Neoplasm (4)Mantle Cell Lymphoma (3)Mixed Phenotype Acute Leukemia (3)
NCT06252753 N/A
Recruiting
Observational Study Protocol: LIVER-R
Condition
Hepatobiliary Cancers
Enrollment
4,490 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT06465810 N/A
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Condition
Transthyretin Amyloidosis
Enrollment
1,850 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Condition
High Grade Glioma
Enrollment
60 pts
Location
United States, Australia, Canada
Sponsor
Rigel Pharmaceuticals
NCT07009288 N/A
Recruiting
A Study of Time-Restricted Eating in Childhood Cancer Survivors
Condition
Childhood Cancer Survivors
Enrollment
300 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06948786 Phase 2
Recruiting
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades ...
Condition
Grade 1 Follicular Lymphoma
Enrollment
22 pts
Location
United States
Sponsor
University of Washington
NCT05213676 Phase 4
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
Condition
Congenital Diaphragmatic Hernia
Enrollment
600 pts
Location
United States
Sponsor
The University of Texas Health
NCT05104983 Phase 2
Recruiting
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Condition
Tuberous Sclerosis Complex
Enrollment
64 pts
Location
United States
Sponsor
Darcy Krueger
NCT05145127 Phase 3
Recruiting
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Wit...
Condition
Hemophilia A
Enrollment
245 pts
Location
United States, Australia, Canada
Sponsor
Pfizer
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT05783323 Phase 2
Recruiting
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Condition
Differentiated Thyroid Cancer
Enrollment
13 pts
Location
United States
Sponsor
Children's Hospital of Philade
NCT05856942 N/A
Recruiting
Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program
Condition
HIV Prevention
Enrollment
458 pts
Location
United States
Sponsor
University of Washington
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
NCT05750498 N/A
Recruiting
A-LiNK: Improving Outcomes in Autoimmune Liver Disease
Condition
Autoimmune Hepatitis
Enrollment
800 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT04294927 N/A
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of P...
Condition
BRCA1 Gene Mutation
Enrollment
3,000 pts
Location
United States, Australia, Belgium
Sponsor
University Medical Center Nijm
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT04965675 Phase 3
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Condition
Chronic Migraine in Children
Enrollment
285 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT04829136 N/A
Recruiting
Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Tra...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
30 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT07228624 Phase 2
Recruiting
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Pati...
Condition
Myelodysplastic/Myeloproliferative Neoplasm
Enrollment
50 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT05632770 N/A
Recruiting
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Target...
Condition
PTSD
Enrollment
424 pts
Location
United States
Sponsor
University of Washington
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT07205822 Phase 3
Recruiting
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 ...
Condition
Breast Cancer
Enrollment
100 pts
Location
United States, China, France
Sponsor
AstraZeneca
NCT06295367 N/A
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Condition
Malignant Solid Neoplasm
Enrollment
760 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT06866405 Phase 3
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vac...
Condition
RSV Infection
Enrollment
550 pts
Location
United States, Argentina, South Africa
Sponsor
Pfizer